PRAXIS BIORESEARCH
2:45 PM - 3:00 PM (EDT), Wednesday, June 7, 2023 ・ Session Room 104C
Praxis Bioresearch is an NIH Innovation Zone Company developing a novel treatment for behavioral problems in Alzheimer's Disease. It's core team consists of scientific and business leaders in CNS drug development with a proven track record in large pharma. Its lead asset, PRX-P4-003 is a novel clinical stage prodrug with protected intellectual propeerty and a validated mechanism.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
CA
Company HQ Country:
United States
Year Founded:
2014
Main Therapeutic Focus:
CNS/Neurological
Lead Product in Development:
PRX-P4-003
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
